Screener
Pulse Biosciences, Inc. PLSE Sales & Marketing
Discontinued — last reported Q4 '23
Sales & Marketing at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketingAndAdvertisingExpense.
The source filing: Pulse Biosciences, Inc.’s 10-K, filed March 28, 2024.
- Filed
- Mar 28, 2024
- Fiscal year
- FY2023
- Accession
- 0001437749-24-009815
| Line item | Year Ended December 31, 2023 | Year Ended December 31, 2022 |
|---|---|---|
| Cost and expenses: | ||
| Cost of revenues | — | 11,944 |
| Research and development | 27,797 | 20,839 |
| Sales and marketing | — | 12,019 |
| General and administrative | 15,777 | 13,955 |
| Total cost and expenses | 43,574 | 58,757 |
| Loss from operations | (43,574) | (58,057) |
| Other income (expense): |
Document
FAQ
- What is Pulse Biosciences, Inc.'s sales & marketing?
- Pulse Biosciences, Inc. (PLSE) reported sales & marketing of $0 in Q4 2023.
- How has Pulse Biosciences, Inc.'s sales & marketing changed year-over-year?
- Pulse Biosciences, Inc.'s sales & marketing decreased by 100.0% year-over-year, from $768K to $0.
- What is the long-term trend for Pulse Biosciences, Inc.'s sales & marketing?
- Over 2 years (2021 to 2023), Pulse Biosciences, Inc.'s sales & marketing has grown at a -100.0% compound annual growth rate (CAGR), from $14.75M to $0.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.
Ask your AI about Pulse Biosciences, Inc.'s sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude